Abiopharma

Piepszak Jennifer 🔴 sold 4.9K shares of JPMORGAN CHASE & CO (JPM) at $309.42 ($1.5M) Transaction Date: May 05, 2026 | Filing ID: 004965

(30% Negative) BOWMAN CONSULTING GROUP LTD. (BWMN) Reports Q2 2026 Financial Results

Director Aggarwal Sanjeev 🔴 sold 28.5K shares of EVERSPIN TECHNOLOGIES INC. (MRAM) at $19.58 Transaction Date: May 04, 2026 | Filing ID: 030750

Director Plourd Martin E 🟡 adjusted position in 40.7K shares (8 derivative) of Community West Bancshares (CWBC) at $23.77 ($2.9M) Transaction Date: May 01, 2026 | Filing ID: 030748

Ohlgart Christiane 🟡 adjusted position in 2.3K shares (4 derivative) of Fortinet, Inc. (FTNT) at $89.70 Transaction Date: May 01, 2026 | Filing ID: 000008

Director SACHS BRUCE I 🟢 acquired 2.9K shares (1 derivative) of VERTEX PHARMACEUTICALS INC / MA (VRTX) at $424.45 ($1.2M) Transaction Date: May 01, 2026 | Filing ID: 000187

PLATT PHILLIP JOHN 🟢 acquired 1.3K shares of Ingevity Corp (NGVT) Transaction Date: May 01, 2026 | Filing ID: 000004

(70% Positive) VIVAKOR INC. (VIVK) Files Form 8-K

📋 Jeremy Barnum (Chief Financial Officer) plans to sell 3K shares of JPMORGAN CHASE & CO. (at $309.41 each, total $935K) Filed: May 05, 2026 | ID: 000008

📋 Ashley Bacon (Chief Risk Officer) plans to sell 4K shares of JPMORGAN CHASE & CO. (at $309.42 each, total $1.3M) Filed: May 05, 2026 | ID: 000006